
CAS 222716-34-9
:SZL P1-41
CAS :Formule :C24H24N2O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :420.52403-(Benzo[D]Thiazol-2-Yl)-6-Ethyl-7-Hydroxy-8-(Piperidin-1-Ylmethyl)-4H-Chromen-4-One
CAS :3-(Benzo[D]Thiazol-2-Yl)-6-Ethyl-7-Hydroxy-8-(Piperidin-1-Ylmethyl)-4H-Chromen-4-OneDegré de pureté :99%Masse moléculaire :420.52g/molSZL P1-41
CAS :SZL P1-41 inhibits Skp2, blocks complex formation, and halts ubiquitination, promoting cell senescence, reducing glycolysis, and exhibiting antitumor effects.Formule :C24H24N2O3SDegré de pureté :99.60% - 99.87%Couleur et forme :SolidMasse moléculaire :420.523-(2-Benzothiazolyl)-6-ethyl-7-hydroxy-8-(1-piperidinylmethyl)-4H-1-benzopyran-4-one
CAS :Produit contrôléStability Hygroscopic
Applications 3-(2-Benzothiazolyl)-6-ethyl-7-hydroxy-8-(1-piperidinylmethyl)-4H-1-benzopyran-4-one is involved in the pharmacological inactivation of Skp2 E3 ligase.
References Chan, C., et al.: Cell, 154, 556-568 (2013)Formule :C24H24N2O3SCouleur et forme :NeatMasse moléculaire :420.52SZL P1-41
CAS :SZL P1-41 is a secretase inhibitor that inhibits the activity of ubiquitin ligases. It has been shown to inhibit the progress of Alzheimer's disease in wild-type mice, and it also inhibits cell growth and proliferation in prostate cancer cells. SZL P1-41 inhibits the fibrillization of amyloid protein by preventing its binding to other proteins, which decreases the production of beta-amyloid peptides. This drug is currently being investigated as a potential anticancer agent due to its ability to inhibit cell cycle progression and induce apoptosis.
Formule :C24H24N2O3SDegré de pureté :Min. 95%Masse moléculaire :420.52 g/mol




